Sarissa Biomedical
2002
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Later Stage VC
LATEST DEAL TYPE
$750K
LATEST DEAL AMOUNT
9
INVESTORS
Description
Developer of novel biosensors designed to offer measurement of neuroactive chemicals during in vitro and in vivo studies for research and clinical diagnostic applications. The company's biosensors are minimally invasive, coupled with a broad linear range and have accuracy and reproducibility, enabling healthcare providers to use them in the measurement of the purines and other neurochemicals, as indicators of neurological activity or disorders.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- Unit 4B, Vanguard Centre
- Sir William Lyons Road, Warwick University Science Park
- Coventry CV4 7EZ
- England, United Kingdom
+44 024 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sarissa Biomedical’s full profile, request a free trial.
Sarissa Biomedical Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 08-Mar-2019 | $750K | 00.00 | 00.000 | Completed | Clinical Trials - General |
| 10. Grant | 17-May-2018 | 00.000 | 00.000 | Completed | Clinical Trials - General | |
| 9. Later Stage VC | 12-Dec-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 8. Later Stage VC | 31-Mar-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 7. Grant | 04-Jul-2016 | 00000 | 00.000 | Completed | Clinical Trials - General | |
| 6. Later Stage VC | 22-Dec-2015 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 5. Later Stage VC | 12-Aug-2014 | 00000 | 00.000 | 00.000 | Completed | Startup |
| 4. Later Stage VC | 02-Dec-2010 | 00000 | 00.00 | 00.000 | Completed | Generating Revenue |
| 3. Grant | 01-Jan-2010 | $898K | Completed | Generating Revenue | ||
| 2. Early Stage VC | 13-Oct-2004 | $898K | $898K | Completed | Startup |
Sarissa Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| A Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| A Ordinary | 00,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
| A Ordinary | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| A Ordinary | 128,138 | $0.013040 | $2.88 | $2.88 | 1x | $2.88 | 15.69% | |
| Preference | 84,779 | $0.013040 | $2.88 | $2.88 | 1x | $2.88 | 10.38% |
Sarissa Biomedical Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Horizon 2020 | Government | 000 0000 | 000000 0 | |||
| Small Business Research Initiative | Government | 000 0000 | 000000 0 | |||
| University of Warwick Foundation | Limited Partner | Minority | 000 0000 | 000000 0 | ||
| Wren Capital | Angel Group | Minority | 000 0000 | 000000 0 | ||
| Advantage West Midlands | Government | 000 0000 | 000000 0 |
Sarissa Biomedical Executive Team (6)
1 Former Executive
You’re viewing 5 of 6 executives. Get the full list »Sarissa Biomedical Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Everard Mascarenhas Ph.D | Sarissa Biomedical | Board Member & Chief Executive Officer | 000 0000 | |
| George Zajicek | Self | Board Member | 000 0000 | |
| Nicholas Dale Ph.D | Sarissa Biomedical | Co-Founder, Chief Technology Officer & Board Member | 000 0000 | |
| Quentin Compton-Bishop | Sarissa Biomedical | Director | 000 0000 | |
| William Moffitt III | Self | Chairman | 000 0000 |
1 Former Board Member
You’re viewing 5 of 6 board members. Get the full list »